Jane Block
Adult Health · Weeki Wachee, FLNPI 1750398608
Payments from drug & device makers
Across 256 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$481
- Bayer$404
- Lilly USA, LLC$378
- Neuronetics, Inc.$246
- Amgen$219
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,697100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 66 | $1,114 |
| Novo Nordisk | 25 | $481 |
| Bayer | 22 | $404 |
| Lilly USA, LLC | 22 | $378 |
| Neuronetics, Inc. | 3 | $246 |
| Amgen | 13 | $219 |
| Pfizer | 10 | $191 |
| Kowa Pharmaceuticals America, Inc. | 11 | $175 |
| Esperion Therapeutics, Inc. | 9 | $158 |
| Amarin Pharma, Inc. | 9 | $154 |
| Idorsia Pharmaceuticals US Inc | 8 | $151 |
| Exact Sciences | 8 | $145 |
| Currax Pharmaceuticals LLC | 10 | $139 |
| GSK | 7 | $126 |
| Boehringer Ingelheim | 5 | $110 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $80 |
| Medtronic | 1 | $45 |
| Abbott | 2 | $44 |
| AbbVie | 2 | $39 |
| Johnson & Johnson | 2 | $36 |
| Novartis | 2 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| IBSA Pharma Inc. | 1 | $24 |
| Boston Scientific | 1 | $24 |
| Inogen, Inc. | 2 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,711 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 75 | $81,398 |
| OzempicSemaglutide | 49 | $65,889 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $44,731 |
| TrulicityDulaglutide | 31 | $32,802 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $30,249 |
| FarxigaDapagliflozin Propanediol | 16 | $21,855 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $21,793 |
| JardianceEmpagliflozin | 12 | $20,425 |
| JanuviaSitagliptin Phosphate | 12 | $15,691 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 14 | $6,679 |
| VascepaIcosapent Ethyl | 16 | $5,733 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $5,495 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $5,197 |
| SynthroidLevothyroxine Sodium | 72 | $4,971 |
| NexletolBempedoic Acid | 12 | $4,928 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $191 | $81,39875 claims |
| Novo NordiskOzempic | $481 | $65,88949 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,114 | $43,64845 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $126 | $35,44635 claims |
| Lilly USA, LLCTrulicity | $378 | $32,80231 claims |
| Boehringer IngelheimJardiance | $110 | $20,42512 claims |
| AbbVieSynthroid | $39 | $4,97172 claims |
| Esperion Therapeutics, Inc.Nexletol | $158 | $4,92812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,237 adult health providers in Florida.
Other adult health in Weeki Wachee
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.